Sign in

NCT03436368Active, not recruiting

Continuous Spinal Anesthesia in Renal Transplantation

Continuous Spinal Anesthesia for Renal Transplant Recipients

Source: ClinicalTrials.gov · Last updated 12 Jan 2026

Brief summary (registry, in English)

Renal transplantation is now recognized as a treatment of choice for patients with end-stage renal disease. An adequate anesthetic technique should achieve hemodynamic stability and enhance perfusion of the transplanted kidney. The aim of this study is to assess the use \& effects of continuous spinal anesthesia for kidney transplantation recipients, compared with balanced general anesthesia.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
12 Feb 2018
Start date
20 Feb 2018
Primary completion date
31 Dec 2026
Lead sponsor
Nazmy Edward Seif
NCT number
NCT03436368

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 20 Feb 2018 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any condition contra-indicating regional anesthesia
  • Allergic to any of the drugs used during the procedure

Other

  • Coagulopathy

Who the study is looking for

  • ASA class III or IV
  • End-stage renal disease
  • Renal transplantation candidate patients

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kasr Al-Ainy Hospital, Cairo University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.